308 related articles for article (PubMed ID: 11049989)
1. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.
Shankar P; Russo M; Harnisch B; Patterson M; Skolnik P; Lieberman J
Blood; 2000 Nov; 96(9):3094-101. PubMed ID: 11049989
[TBL] [Abstract][Full Text] [Related]
2. CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects.
Huang XL; Fan Z; Kalinyak C; Mellors JW; Rinaldo CR
Clin Diagn Lab Immunol; 2000 Mar; 7(2):279-87. PubMed ID: 10702505
[TBL] [Abstract][Full Text] [Related]
3. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
4. Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients: dual effects of highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Martinez P; Kuroda M; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2003 Nov; 34(3):255-66. PubMed ID: 14600569
[TBL] [Abstract][Full Text] [Related]
5. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
mBio; 2016 May; 7(3):. PubMed ID: 27247230
[TBL] [Abstract][Full Text] [Related]
6. CD8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses.
Arrode G; Finke JS; Zebroski H; Siegal FP; Steinman RM
Eur J Immunol; 2005 Jan; 35(1):159-70. PubMed ID: 15580653
[TBL] [Abstract][Full Text] [Related]
7. Distinct kinetics of Gag-specific CD4+ and CD8+ T cell responses during acute HIV-1 infection.
Riou C; Ganusov VV; Campion S; Mlotshwa M; Liu MK; Whale VE; Goonetilleke N; Borrow P; Ferrari G; Betts MR; Haynes BF; McMichael AJ; Gray CM
J Immunol; 2012 Mar; 188(5):2198-206. PubMed ID: 22287716
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
[TBL] [Abstract][Full Text] [Related]
9. Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection.
Boaz MJ; Waters A; Murad S; Easterbrook PJ; Vyakarnam A
J Immunol; 2002 Dec; 169(11):6376-85. PubMed ID: 12444145
[TBL] [Abstract][Full Text] [Related]
10. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
[TBL] [Abstract][Full Text] [Related]
11. Impaired IFN-gamma production by viral immunodominant peptide-specific tetramer+ CD8+ T cells in HIV-1 infected patients is not secondary to HAART.
Onlamoon N; Pattanapanyasat K; Ansari AA
Clin Dev Immunol; 2004; 11(3-4):287-98. PubMed ID: 15559376
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.
Vali B; Tohn R; Cohen MJ; Sakhdari A; Sheth PM; Yue FY; Wong D; Kovacs C; Kaul R; Ostrowski MA
J Virol; 2011 Jan; 85(1):254-63. PubMed ID: 20980521
[TBL] [Abstract][Full Text] [Related]
13. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
14. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.
Wedemeyer H; He XS; Nascimbeni M; Davis AR; Greenberg HB; Hoofnagle JH; Liang TJ; Alter H; Rehermann B
J Immunol; 2002 Sep; 169(6):3447-58. PubMed ID: 12218168
[TBL] [Abstract][Full Text] [Related]
15. Frequencies of ex vivo-activated human immunodeficiency virus type 1-specific gamma-interferon-producing CD8+ T cells in infected children correlate positively with plasma viral load.
Buseyne F; Scott-Algara D; Porrot F; Corre B; Bellal N; Burgard M; Rouzioux C; Blanche S; Rivière Y
J Virol; 2002 Dec; 76(24):12414-22. PubMed ID: 12438567
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
[TBL] [Abstract][Full Text] [Related]
17. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation.
Trimble LA; Shankar P; Patterson M; Daily JP; Lieberman J
J Virol; 2000 Aug; 74(16):7320-30. PubMed ID: 10906185
[TBL] [Abstract][Full Text] [Related]
19. HIV-specific IL-2(+) and/or IFN-γ(+) CD8(+) T cell responses during chronic HIV-1 infection in former blood donors.
Feng YM; Wan YM; Liu LX; Qiu C; Ma PF; Peng H; Ruan YH; Han LF; Hong KX; Xing H; Shao YM
Biomed Environ Sci; 2010 Oct; 23(5):391-401. PubMed ID: 21112488
[TBL] [Abstract][Full Text] [Related]
20. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
López M; Soriano V; Lozano S; Martinez P; Sempere J; González-Lahoz J; Benito J
AIDS Res Hum Retroviruses; 2006 Sep; 22(9):884-92. PubMed ID: 16989614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
